Stroke: Difference between revisions

Jump to navigation Jump to search
(4 intermediate revisions by the same user not shown)
Line 5: Line 5:


==Causes==
==Causes==
#[[Ischemic stroke]]
{| class="wikitable"
! colspan="4" |Cause
|-
!Disease
!Lethal causes
!Common causes
!Less common causes
|-
|[[Transient ischemic attack]] (TIA)
|Emboli from cardiac source (mostly secondary to AF)
|
* Atherosclerotic plaque
* Thrombosis
|Arterial dissection
|-
|Ischemic stroke
|
* [[Atrial fibrillation]]
* [[Eclampsia]]
* [[Infective endocarditis]]
* [[Myocardial infarction]]
* [[Pulmonary embolism]]
|
* [[Aneurysm]]
* [[Arteriovenous malformations]]
* [[Atherosclerosis]]
* [[Atrial fibrillation]]
* [[Embolism]]
* [[Hypertension]]
* [[Subarachnoid hemorrhage]]
* [[Thrombosis]]
* [[Transient ischemic attack]]
* [[Traumatic brain injury]]
* [[Warfarin]]
|
* [[Takayasu arteritis]]
* [[Vasculitis]]
* [[Vasoconstriction]]
 
* [[Infective endocarditis]]
* [[Lacunar infarcts]]
* [[Left atrial myxoma]]
|-
|Intracerebral hemorrhage
| ---
|
* [[Hypertension|Long-standing hypertension]]
 
* [[Cerebral amyloid angiopathy]]
|
* [[Arteriovenous malformation|Arteriovenous malformations (AVMs)]]
* [[Aneurysms]]
 
* [[Cocaine]]
* [[Amphetamines]]
 
* [[Vasculitis]]
 
* [[Liver disease]]
* Anticoagulant medication
* [[Thrombolytic therapy]]
 
* [[Tumor|Brain tumor]]
* Hemorrhagic transformation of an ischemic stroke
* [[Moyamoya disease]]
* [[Tumor|Tumors]]
 
* [[Encephalitis]]
|-
|
|
|
|
|}


==Classification==
==Classification==
===Transient ischemic attack===
*A transient ischemic attack is caused by the temporary disturbance of blood supply to a restricted area of the brain, resulting in brief neurologic dysfunction that usually persists for less than 24 hours.
===Stroke===
{{familytree/start |summary=Stroke}}
{{familytree | | | | | | | | | | | | | | | | A01 |A01='''Stroke'''}}
{{familytree | | | | | |,|-|-|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|.| | | }}
{{familytree | | | | | B01 | | | | | | | | | | | | | | | | | | | B02 | | |B01=[[Ischemic stroke|Ischemic]]|B02=[[Hemorrhagic stroke|Hemorrhagic]]}}
{{familytree | |,|-|-|-|+|-|-|-|.| | | |,|-|-|-|-|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.|}}
{{familytree | D01 | | D02 | | D03 | | D04 | | | | | | | | | | | | | | | | | | | D05 |D01=Large vessel thromboembolism|D02=Cardioembolic|D03=Small vessel or Lacunar infarct|D04=Intra-axial|D05=Extra-axial}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | |!|}}
{{familytree | | | | | | | | | | | | | |)|-|-|-|-|.|,|-|-|-|-|-|-|-|-|v|-|-|-|-|-|^|-|-|-|-|.}}
{{familytree | | | | | | | | | | | | | E01 | | | E02 | | | | | | | | E03 | | | | | | | | | E04 |E01=[[Intracerebral hemorrhage|Intracerebral]] (ICH)|E02=[[Subarachnoid hemorrhage]] (SAH)|E03=[[Subdural hematoma|Subdural Hemorrhage]]|E04=[[Epidural hematoma|Epidural Hemorrhage]]}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }}
{{familytree | | | | | | F01 | | | | | F02 | | | | | F03 |F01=[[Intraparenchymal hemorrhage|Intraparenchymal hemorrhage]]|F02=[[Intraventricular hemorrhage]] (IVH)|F03=Cerebral microbleeds
}}
{{familytree/end}}


==Differential diagnosis==
==Differential diagnosis==
Line 13: Line 103:
|-style="background: #4479BA; color: #FFFFFF; text-align: center;"
|-style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
! colspan="4" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="5" |<small>Physical Examination</small>
! colspan="5" |<small>Physical Examination</small>
! colspan="4" |<small>Symptoms
! colspan="4" |<small>Symptoms
Line 19: Line 109:
! rowspan="2" |<small>Other Findings</small>
! rowspan="2" |<small>Other Findings</small>
|-style="background: #4479BA; color: #FFFFFF; text-align: center;"
|-style="background: #4479BA; color: #FFFFFF; text-align: center;"
!<small>Na+, K+, Ca2+</small>
!<small>CT /MRI</small>
!<small>CT /MRI</small>
!<small>CSF Findings</small>
!<small>CSF Findings</small>
Line 35: Line 124:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" | Brain tumour<ref name="pmid10582668">{{cite journal| author=Morgenstern LB, Frankowski RF| title=Brain tumor masquerading as stroke. | journal=J Neurooncol | year= 1999 | volume= 44 | issue= 1 | pages= 47-52 | pmid=10582668 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10582668  }} </ref>
|style="background: #DCDCDC; padding: 5px; text-align: center;" | Brain tumour<ref name="pmid10582668">{{cite journal| author=Morgenstern LB, Frankowski RF| title=Brain tumor masquerading as stroke. | journal=J Neurooncol | year= 1999 | volume= 44 | issue= 1 | pages= 47-52 | pmid=10582668 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10582668  }} </ref>
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px; text-align:center"|✔
|style="background: #F5F5F5; padding: 5px; text-align:center"|✔
|style="background: #F5F5F5; padding: 5px text-align:center" |Cancer cells<ref name="pmid21371327">{{cite journal| author=Weston CL, Glantz MJ, Connor JR| title=Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. | journal=Fluids Barriers CNS | year= 2011 | volume= 8 | issue= 1 | pages= 14 | pmid=21371327 | doi=10.1186/2045-8118-8-14 | pmc=3059292 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21371327  }}</ref>
|style="background: #F5F5F5; padding: 5px text-align:center" |Cancer cells<ref name="pmid21371327">{{cite journal| author=Weston CL, Glantz MJ, Connor JR| title=Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. | journal=Fluids Barriers CNS | year= 2011 | volume= 8 | issue= 1 | pages= 14 | pmid=21371327 | doi=10.1186/2045-8118-8-14 | pmc=3059292 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21371327  }}</ref>
Line 52: Line 140:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemorrhagic stroke
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemorrhagic stroke
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px; text-align:center" |✔
|style="background: #F5F5F5; padding: 5px; text-align:center" |✔
|style="background: #F5F5F5; padding: 5px;" |Xanthochromia<ref name="pmid1198628">{{cite journal| author=Lee MC, Heaney LM, Jacobson RL, Klassen AC| title=Cerebrospinal fluid in cerebral hemorrhage and infarction. | journal=Stroke | year= 1975 | volume= 6 | issue= 6 | pages= 638-41 | pmid=1198628 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1198628  }}</ref>
|style="background: #F5F5F5; padding: 5px;" |Xanthochromia<ref name="pmid1198628">{{cite journal| author=Lee MC, Heaney LM, Jacobson RL, Klassen AC| title=Cerebrospinal fluid in cerebral hemorrhage and infarction. | journal=Stroke | year= 1975 | volume= 6 | issue= 6 | pages= 638-41 | pmid=1198628 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1198628  }}</ref>
Line 69: Line 156:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" | Subdural hemorrhage
|style="background: #DCDCDC; padding: 5px; text-align: center;" | Subdural hemorrhage
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px; text-align:center" |✔
|style="background: #F5F5F5; padding: 5px; text-align:center" |✔
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 86: Line 172:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Neurosyphilis<ref name="pmid22482824">{{cite journal| author=Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG et al.| title=Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. | journal=J Neurol Sci | year= 2012 | volume= 317 | issue= 1-2 | pages= 35-9 | pmid=22482824 | doi=10.1016/j.jns.2012.03.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22482824  }} </ref><ref name="pmid24365430">{{cite journal |vauthors=Berger JR, Dean D |title=Neurosyphilis |journal=Handb Clin Neurol |volume=121 |issue= |pages=1461–72 |year=2014 |pmid=24365430 |doi=10.1016/B978-0-7020-4088-7.00098-5 |url=}}</ref>
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Neurosyphilis<ref name="pmid22482824">{{cite journal| author=Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG et al.| title=Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. | journal=J Neurol Sci | year= 2012 | volume= 317 | issue= 1-2 | pages= 35-9 | pmid=22482824 | doi=10.1016/j.jns.2012.03.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22482824  }} </ref><ref name="pmid24365430">{{cite journal |vauthors=Berger JR, Dean D |title=Neurosyphilis |journal=Handb Clin Neurol |volume=121 |issue= |pages=1461–72 |year=2014 |pmid=24365430 |doi=10.1016/B978-0-7020-4088-7.00098-5 |url=}}</ref>
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px; text-align:center" |✔
|style="background: #F5F5F5; padding: 5px; text-align:center" |✔
|style="background: #F5F5F5; padding: 5px;" |'''↑''' [[Leukocytes]] and [[protein]]
|style="background: #F5F5F5; padding: 5px;" |'''↑''' [[Leukocytes]] and [[protein]]
Line 106: Line 191:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Complex or atypical migraine
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Complex or atypical migraine
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 123: Line 207:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypertensive encephalopathy
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypertensive encephalopathy
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 140: Line 223:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Wernicke’s encephalopathy
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Wernicke’s encephalopathy
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 157: Line 239:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |CNS abscess
|style="background: #DCDCDC; padding: 5px; text-align: center;" |CNS abscess
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |'''↑''' leukocytes, '''↓''' glucose and '''↑''' protien  
|style="background: #F5F5F5; padding: 5px;" |'''↑''' leukocytes, '''↓''' glucose and '''↑''' protien  
Line 174: Line 255:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Drug toxicity
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Drug toxicity
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 191: Line 271:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Conversion disorder  
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Conversion disorder  
| style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 208: Line 287:
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Electrolyte disturbance
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Electrolyte disturbance
|style="background: #F5F5F5; padding: 5px; text-align:center" |'''↓''' or '''↑'''
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
|style="background: #F5F5F5; padding: 5px;" |
Line 225: Line 303:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meningitis or encephalitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meningitis or encephalitis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |'''↑''' Leukocytes,
| style="background: #F5F5F5; padding: 5px; text-align:center" |'''↑''' Leukocytes,
Line 247: Line 324:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis exacerbation
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis exacerbation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |'''↑'''  CSF IgG levels
| style="background: #F5F5F5; padding: 5px; text-align:center" |'''↑'''  CSF IgG levels
Line 265: Line 341:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Seizure
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Seizure
| style="background: #F5F5F5; padding: 5px; text-align:center" |↓ or '''↑'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 282: Line 357:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypoglycemia  
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypoglycemia  
| style="background: #F5F5F5; padding: 5px; text-align:center" |↓ or '''↑'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 20:11, 23 March 2017

Stroke Main page

Patient Information

Overview

Causes

Classification

Hemorrhagic stroke
Ischemic stroke

Differentiating Stroke from other Diseases

Epidemiology and Demographics

Diagnosis

NIH stroke scale
Glasgow coma scale

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stroke On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stroke

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stroke

CDC on Stroke

Stroke in the news

Blogs on Stroke

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Stroke

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]; Tarek Nafee, M.D. [3]; Sara Mehrsefat, M.D. [4]

Overview

Causes

Cause
Disease Lethal causes Common causes Less common causes
Transient ischemic attack (TIA) Emboli from cardiac source (mostly secondary to AF)
  • Atherosclerotic plaque
  • Thrombosis
Arterial dissection
Ischemic stroke
Intracerebral hemorrhage ---

Classification

Transient ischemic attack

  • A transient ischemic attack is caused by the temporary disturbance of blood supply to a restricted area of the brain, resulting in brief neurologic dysfunction that usually persists for less than 24 hours.

Stroke

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stroke
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ischemic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemorrhagic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Large vessel thromboembolism
 
Cardioembolic
 
Small vessel or Lacunar infarct
 
Intra-axial
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extra-axial
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intracerebral (ICH)
 
 
Subarachnoid hemorrhage (SAH)
 
 
 
 
 
 
 
Subdural Hemorrhage
 
 
 
 
 
 
 
 
Epidural Hemorrhage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intraparenchymal hemorrhage
 
 
 
 
Intraventricular hemorrhage (IVH)
 
 
 
 
Cerebral microbleeds

Differential diagnosis

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
CT /MRI CSF Findings Gold standard test Motor Deficit Sensory deficit Speech difficulty Gait abnormality Cranial nerves Headache LOC Motor weakness Abnormal sensations
Brain tumour[1] Cancer cells[2] MRI Cachexia, gradual progression of symptoms
Hemorrhagic stroke Xanthochromia[3] CT scan without contrast[4][5] Hypertension Neck stiffness
Subdural hemorrhage CT scan without contrast[4][5] Trauma/fall Confusion, dizziness, nausea, vomiting
Neurosyphilis[6][7] Leukocytes and protein CSF VDRL-specifc

CSF FTA-Ab -sensitive[8]

STIs Blindness, confusion, depression,

Abnormal gait

Complex or atypical migraine Clinical assesment Family history of migraine Presence of aura, nausea, vomiting
Hypertensive encephalopathy Clinical assesment History of hypertension Delirium, cortical blindness, cerebral edema, seizure
Wernicke’s encephalopathy History of alcohal abuse Ophthalmoplegia, confusion
CNS abscess leukocytes, glucose and protien MRI is more sensitive and specific History of drug abuse, endocarditis, immune status High grade fever, fatigue,nausea, vomiting
Drug toxicity Lithium, Sedatives, phenytoin, carbamazepine
Conversion disorder Diagnosis of exclusion Tremors, blindness, difficulty swallowing
Electrolyte disturbance Depends on the cause Confusion, seizures
Meningitis or encephalitis Leukocytes,

Protein

↓ Glucose

CSF analysis[9] Fever, neck

rigidity

Multiple sclerosis exacerbation CSF IgG levels

(monoclonal bands)

Clinical assesment and MRI [10] History of relapses and remissions Blurry vision, urinary incontinence, fatigue
Seizure Clinical assesment and EEG [11] Previous history of seizures Confusion, apathy, irritability,
Hypoglycemia Serum blood glucose

HbA1c

History of diabetes Palpitations, sweating, dizziness, low serum, glucose

Epidemiology and Demographics

Stroke in USA

  • Stroke is a leading cause of serious long-term disability
  • In USA, the incidence and mortality rates of stroke has significantly decreased compared to previous years.
  • From year 2003 to 2013, the mortality rates due to stroke declined by 18.5%.[12]
  • In 2013, stroke became the fifth leading cause of death.
  • The case fatality rate of stroke is estimated to be 41.7 deaths per 100, 000 population[12]
  • The incidence of new (610, 000) or recurrent stroke (185, 000) is estimated to be 795000 people annually or 250 cases per 100, 000.[12]
  • It is estimated that one incidence of stroke happens every 4 sec with death occuring every 4 min.[12]
  • About 87% of all strokes are ischemic strokes[13]
  • Stroke costs the United States an estimated $34 billion each year[13]

Worldwide

  • According to WHO, the incidence of stroke is estimated to be 15 million people annually, worldwide.[14].
  • Out of these, 5 million die and 5 million are left permanently disbaled.[14].

Age

  • Stroke can occur in all age groups. However, the incidence of stroke is less among individuals age less than 40 years of age and the risk increases with increasing age. [13]
  • According to WHO, stroke also occurs in about 8% of children with sickle cell disease.[14].
  • In 2009, 34% of people hospitalized for stroke were younger than 65 years[13]
  • The incidence of stroke in people aged 18 to 50 years is estimated to be approximately 10%. [12]

The rate of decline in mortality rates of stroke in different age groups is as follows:[12]

  • >65 years of age: from 534.1 to 245.2 per 100,000
  • 45-65 years of age: from 43.5 to 20.2 per 100,000
  • 18 to 44 years of age: from from 3.7 to 2.0 per 100,000

Gender

There is increased incidence of stroke in men as compared to women.

Race

  • The risk of incidence of first stroke is twice in african american population as compared to whites with increased mortality rates.[13]
  • Hispanics’ risk for stroke falls between that of whites and blacks [13]

Geographical distribution

  • There is increased incidence and mortality rates of stroke in developing countries as compared to developed countries due to low socio economic status and heath facilites.
  • In USA, the highest death rates from stroke are in the southeastern United States.[13]

Diagnosis

References

  1. Morgenstern LB, Frankowski RF (1999). "Brain tumor masquerading as stroke". J Neurooncol. 44 (1): 47–52. PMID 10582668.
  2. Weston CL, Glantz MJ, Connor JR (2011). "Detection of cancer cells in the cerebrospinal fluid: current methods and future directions". Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
  3. Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). "Cerebrospinal fluid in cerebral hemorrhage and infarction". Stroke. 6 (6): 638–41. PMID 1198628.
  4. 4.0 4.1 Birenbaum D, Bancroft LW, Felsberg GJ (2011). "Imaging in acute stroke". West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
  5. 5.0 5.1 DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). "ACR Appropriateness Criteria® on cerebrovascular disease". J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
  6. Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). "Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients". J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
  7. Berger JR, Dean D (2014). "Neurosyphilis". Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
  8. Ho EL, Marra CM (2012). "Treponemal tests for neurosyphilis--less accurate than what we thought?". Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.
  9. Carbonnelle E (2009). "[Laboratory diagnosis of bacterial meningitis: usefulness of various tests for the determination of the etiological agent]". Med Mal Infect. 39 (7–8): 581–605. doi:10.1016/j.medmal.2009.02.017. PMID 19398286.
  10. Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH; et al. (1994). "Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group". Arch Neurol. 51 (1): 61–6. PMID 8274111.
  11. Manford M (2001). "Assessment and investigation of possible epileptic seizures". J Neurol Neurosurg Psychiatry. 70 Suppl 2: II3–8. PMC 1765557. PMID 11385043.
  12. 12.0 12.1 12.2 12.3 12.4 12.5 Writing Group Members. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ; et al. (2016). "Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association". Circulation. 133 (4): e38–360. doi:10.1161/CIR.0000000000000350. PMID 26673558.
  13. 13.0 13.1 13.2 13.3 13.4 13.5 13.6 http://www.cdc.gov/stroke/facts.htm Accessed on November 3, 2016
  14. 14.0 14.1 14.2 Mackay, Judith, et al. The atlas of heart disease and stroke. World Health Organization, 2004 Accessed on November 3 2016

Template:WS Template:WH